DOI QR코드

DOI QR Code

Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848

  • Liu, Chun-Ying (College of Biotechnology, Dalian Polytechnic University) ;
  • Zhou, Rui-Xin (College of Biotechnology, Dalian Polytechnic University) ;
  • Sun, Chang-Kai (Institute for Brain Disorders, Dalian Medical University) ;
  • Jin, Ying-Hua (Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, College of Life Science, Jilin University) ;
  • Yu, Hong-Shan (College of Biotechnology, Dalian Polytechnic University) ;
  • Zhang, Tian-Yang (College of Biotechnology, Dalian Polytechnic University) ;
  • Xu, Long-Quan (College of Biotechnology, Dalian Polytechnic University) ;
  • Jin, Feng-Xie (College of Biotechnology, Dalian Polytechnic University)
  • 투고 : 2014.10.14
  • 심사 : 2014.12.19
  • 발행 : 2015.07.15

초록

Background: Minor ginsenosides, those having low content in ginseng, have higher pharmacological activities. To obtain minor ginsenosides, the biotransformation of American ginseng protopanaxadiol (PPD)-ginsenoside was studied using special ginsenosidase type-I from Aspergillus niger g.848. Methods: DEAE (diethylaminoethyl)-cellulose and polyacrylamide gel electrophoresis were used in enzyme purification, thin-layer chromatography and high performance liquid chromatography (HPLC) were used in enzyme hydrolysis and kinetics; crude enzyme was used in minor ginsenoside preparation from PPD-ginsenoside; the products were separated with silica-gel-column, and recognized by HPLC and NMR (Nuclear Magnetic Resonance). Results: The enzyme molecular weight was 75 kDa; the enzyme firstly hydrolyzed the C-20 position 20-O-${\beta}$-D-Glc of ginsenoside Rb1, then the C-3 position 3-O-${\beta}$-D-Glc with the pathway $Rb1{\rightarrow}Rd{\rightarrow}F2{\rightarrow}C-K$. However, the enzyme firstly hydrolyzed C-3 position 3-O-${\beta}$-D-Glc of ginsenoside Rb2 and Rc, finally hydrolyzed 20-O-L-Ara with the pathway $Rb2{\rightarrow}C-O{\rightarrow}C-Y{\rightarrow}C-K$, and $Rc{\rightarrow}C-Mc1{\rightarrow}C-Mc{\rightarrow}C-K$. According to enzyme kinetics, $K_m$ and $V_{max}$ of Michaelis-Menten equation, the enzyme reaction velocities on ginsenosides were Rb1 > Rb2 > Rc > Rd. However, the pure enzyme yield was only 3.1%, so crude enzyme was used for minor ginsenoside preparation. When the crude enzyme was reacted in 3% American ginseng PPD-ginsenoside (containing Rb1, Rb2, Rc, and Rd) at $45^{\circ}C$ and pH 5.0 for 18 h, the main products were minor ginsenosides C-Mc, C-Y, F2, and C-K; average molar yields were 43.7% for C-Mc from Rc, 42.4% for C-Y from Rb2, and 69.5% for F2 and C-K from Rb1 and Rd. Conclusion: Four monomer minor ginsenosides were successfully produced (at low-cost) from the PPD-ginsenosides using crude enzyme.

키워드

참고문헌

  1. Jin FX. Biotransformation of natural products. Beijing: Chemical Industry Press; 2009. p. 74-113 [in Chinese].
  2. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
  3. Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009;55:1-99.
  4. Liu CY, Song JG, Li PF, Yu HS, Jin FX. Ginsenoside contents in three different ginseng. J Dalian Polytechnic Univ 2011;30:79-82.
  5. Kobashi K. Glycosides are natural prodrugs - evidence using germ-free and gnotobiotic rats associated with a human intestinal bacterium. J Trad Med 1998;15:1-13.
  6. Bae EA, Shin JE, Kim DH. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Bio Pharm Bull 2005;28:1903-8. https://doi.org/10.1248/bpb.28.1903
  7. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradatin of ginsenosides in humans after administration. Drug Metab Dispos 2003;31: 1065-71. https://doi.org/10.1124/dmd.31.8.1065
  8. Cui CH, Kim SC, Im WT. Characterization of the ginsenoside transforming recombinant ${\beta}$-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Appl Microbiol Biotech 2013;97: 649-59. https://doi.org/10.1007/s00253-012-4324-5
  9. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 1996;62:453-7. https://doi.org/10.1055/s-2006-957938
  10. Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol 2010;87:9-19. https://doi.org/10.1007/s00253-010-2567-6
  11. Leung KW, Wong AS. Pharmacology of ginsenosides: a literature review. Chin Med 2010;5:20-2. https://doi.org/10.1186/1749-8546-5-20
  12. Choi S, Kim TW, Singh SV. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1- dependent inhibition of cyclin-dependent kinases. Pharm Res 2009;26: 2280-8. https://doi.org/10.1007/s11095-009-9944-9
  13. Choi SH, Shin TJ, Hwang SH, Lee BH, Kang J, Kim HJ. Differential effects of ginsenoside metabolites on HERG k channel currents. J Ginseng Res 2011;35: 191-9. https://doi.org/10.5142/jgr.2011.35.2.191
  14. Kim YJ, Yamabe N, Choi P, Lee JW, Ham J, Kang KS. Efficient thermal deglycosylation of ginsenoside Rd and its contribution to the improved anticancer activity of ginseng. J Agric Food Chem 2013;61:9185-91. https://doi.org/10.1021/jf402774d
  15. Kim SJ, Kang BY, Cho SY, Sung DS, Chang HK, Yeom MH, Kim DH, Sim YC, Lee YS. Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin. Biochem Biophys Res Commun 2004;316:348-55. https://doi.org/10.1016/j.bbrc.2004.02.046
  16. Kim M, Ahn BY, Lee JS, Chung SS, Lim S, Park SG, Jung HS, Lee HK, Park KS. The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. Biochem Biophys Res Commun 2009;389:70-3. https://doi.org/10.1016/j.bbrc.2009.08.088
  17. Lee JH, Ahn JY, Shin TJ, Choi SH, Lee BH, Hwang SH. Effects of minor ginsenosides, ginsenoside metabolites, and ginsenoside epimers on the growth of Caenorhabditis elegans. J Ginseng Res 2011;35:375-83. https://doi.org/10.5142/jgr.2011.35.3.375
  18. Sala F, Mulet J, Choi S, Jung SY, Nah SY, Rhim H, Valor LM, Criado M, Sala S. Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther 2002;301:1052-9. https://doi.org/10.1124/jpet.301.3.1052
  19. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004;95:153-7. https://doi.org/10.1254/jphs.FMJ04001X4
  20. Popovich DG, Kitts DD. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002;406:1-8. https://doi.org/10.1016/S0003-9861(02)00398-3
  21. Cui CH, Liu QM, Kim JK, Sung BH, Kim SG, Kim SC, Im WT. Identification and characterization of Mucilaginibacter sp. QM49 ${\beta}$-glucosidase and its use in producing the pharmaceutically active minor ginsenosides, Rh1(S) and Rg2(S). Appl Environ Microbiol 2013;79:5788-98. https://doi.org/10.1128/AEM.01150-13
  22. Jin XF, Yu HS, Wang DM, Liu TQ, Liu CY, An DS, Im WT, Kim SG, Jin FX. Kinetics of a cloned special ginsenosidase hydrolyzing 3-O-glucoside of multiprotopanaxadiol- type ginsenosides, named ginsenosidase type III. J Microbiol Biotechnol 2012;22:343-51. https://doi.org/10.4014/jmb.1107.07066
  23. Yu HS, Zhang CZ, Lu MC, Sun F, Fu YY, Jin FX. Purification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type I. Chem Pharm Bull 2007;55:231-5. https://doi.org/10.1248/cpb.55.231
  24. Liu CY, Jin YH, Yu HS, Sun CK, Gao P, Xiao YK, Zhang TY, Xu LQ, Im WT, Jin FX. Biotransformation pathway and kinetics of ginsenosidase type I hydrolyzing 3-O- and 20-O-multi- glucosides of PPD type ginsenosides. Process Biochem 2014;49:813-20. https://doi.org/10.1016/j.procbio.2014.02.011
  25. Yu HS, Liu QM, Zhang CZ, Lu MC, Fu YY, Im WT, Lee ST, Jin FX. A new ginsenosidase from Aspergillus strain hydrolyzing 20-O-multi-glycoside of PPD ginsenoside. Process Biochem 2009;44:772-5. https://doi.org/10.1016/j.procbio.2009.02.005
  26. Wang DM, Yu HS, Song JG, Xu YF, Jin FX. Enzyme kinetics of ginsenosidase type IV hydrolyzing 6-O-multi-glycosides of protopanaxatriol type ginsenosides. Process Biochem 2012;47:133-8. https://doi.org/10.1016/j.procbio.2011.10.026
  27. Li JW. Methods for biochemistry. Beijing: University Press; 1997. p. 189-96 [in Chinese].
  28. Wang JY. Biochemistry. Beijing: Higher Education Press; 2002. p. 356-61 [in Chinese].
  29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
  30. Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;56:658-66. https://doi.org/10.1021/ja01318a036
  31. Tanaka I, Kasai R. Saponins of ginseng and related plants. Progress in the chemistry of organic natural products, vol. 46. Berlin: Springer; 1984. p. 1-76.

피인용 문헌

  1. Compound K derived from ginseng: neuroprotection and cognitive improvement vol.7, pp.11, 2015, https://doi.org/10.1039/c6fo01077f
  2. Purification and characterization of a novel ginsenoside Rc-hydrolyzing β-glucosidase from Armillaria mellea mycelia vol.6, pp.None, 2016, https://doi.org/10.1186/s13568-016-0277-x
  3. Classification of glycosidases that hydrolyze the specific positions and types of sugar moieties in ginsenosides vol.36, pp.6, 2015, https://doi.org/10.3109/07388551.2015.1083942
  4. A literature update elucidating production of Panax ginsenosides with a special focus on strategies enriching the anti-neoplastic minor ginsenosides in ginseng preparations vol.101, pp.10, 2015, https://doi.org/10.1007/s00253-017-8279-4
  5. Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products vol.26, pp.5, 2015, https://doi.org/10.1007/s10068-017-0159-2
  6. Lactobacillus plantarum을 이용한 산양삼 추출물의 진세노사이드 Rg1 및 Rg5의 함량 증대 vol.45, pp.4, 2015, https://doi.org/10.4014/mbl.1711.11001
  7. Conversion of Ginsenoside Rb1 into Six Types of Highly Bioactive Ginsenoside Rg3 and Its Derivatives by FeCl3 Catalysis vol.66, pp.9, 2015, https://doi.org/10.1248/cpb.c18-00426
  8. Protective effects of enhanced minor ginsenosides in Lactobacillus fermentum KP-3-fermented ginseng in mice fed a high fat diet vol.9, pp.11, 2018, https://doi.org/10.1039/c8fo01056k
  9. Biotransformation of ginsenoside using covalently immobilized snailase enzyme onto activated carrageenan gel beads vol.42, pp.1, 2015, https://doi.org/10.1007/s12034-019-1730-7
  10. Antiphotoaging and Antimelanogenesis Properties of Ginsenoside C‐Y, a Ginsenoside Rb2 Metabolite from American Ginseng PDD‐ginsenoside vol.95, pp.6, 2015, https://doi.org/10.1111/php.13116
  11. Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives vol.104, pp.9, 2015, https://doi.org/10.1007/s00253-020-10455-9
  12. Biotransformation of Protopanaxadiol-Type Ginsenosides in Korean Ginseng Extract into Food-Available Compound K by an Extracellular Enzyme from Aspergillus niger vol.30, pp.10, 2015, https://doi.org/10.4014/jmb.2007.07003
  13. Screening ginseng saponins in progenitor cells identifies 20(R)-ginsenoside Rh 2 as an enhancer of skeletal and cardiac muscle regeneration vol.10, pp.None, 2015, https://doi.org/10.1038/s41598-020-61491-4
  14. Cardioprotective effects of Ginsenoside compound-Mc1 and Dendrobium Nobile Lindl against myocardial infarction in an aged rat model: Involvement of TLR4/NF-κB signaling pathway vol.19, pp.None, 2015, https://doi.org/10.1177/20587392211000577
  15. Complete Bioconversion of Protopanaxadiol-Type Ginsenosides to Compound K by Extracellular Enzymes from the Isolated Strain Aspergillus tubingensis vol.69, pp.1, 2021, https://doi.org/10.1021/acs.jafc.0c07424
  16. Production of minor ginsenosides by combining Stereum hirsutum and cellulase vol.16, pp.8, 2015, https://doi.org/10.1371/journal.pone.0255899
  17. In Vitro Evaluation of Anti-Lung Cancer and Anti-COVID-19 Effects using Fermented Black Color Ginseng Extract vol.16, pp.9, 2015, https://doi.org/10.1177/1934578x211034387